GL1X · GenesisL1 explorer

MolNFT v1 · #174289 · protein

Cereblon in complex with SALL4 and (S)-thalidomide

7BQU · Protein cereblon: “Cereblon in complex with SALL4 and (S)-thalidomide”. X-ray diffraction, 2 ligands (EF2, ZN), 2 pockets (best druggability 0.57). MolNFT v1 #174289 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7BQU
Type
protein
Length
133 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein cereblon; Sal-like protein 4
UniProt
Q96SW2, Q9UJQ4
Ligands
EF2, ZN
Pockets
2 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 12% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein cereblonprotein1096% helix, 49% strandQ96SW2
BSal-like protein 4protein2442% helix, 17% strandQ9UJQ4

Ligands and binding sites

  • EF2 · S-Thalidomide · ligand · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11210.570.8326EF2
21090.410.7617empty

Interfaces

1 interface between chains.

  • A–B · 425 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 7BQU · Cereblon in complex with SALL4 and (S)-thalidomide · the same entry in another collection · chain A against A, TM-score 1.00
  • Q96SW2 · AlphaFold monomer V2.0 prediction for protein cereblon (Q96SW2) · a predicted model of the same protein · chain A against A, TM-score 0.96
  • Q9UJQ4 · AlphaFold monomer V2.0 prediction for sal-like protein 4 (Q9UJQ4) · a predicted model of the same protein · chain B against A, TM-score 0.83

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.